HONG KONG – A Guangzhou-based biotech company is working with one of the most prestigious universities in China to build a new institute and raise a fund to drive the development of stem cell and regenerative medicine projects. Read More
HONG KONG — Researchers here have elucidated a previously unknown signaling pathway involved in mediating the synaptic dysfunctions associated with Alzheimer's disease (AD) and have identified a promising new small-molecule disease-modifying intervention that may delay progress of the disease. Read More
TOKYO – Despite a protest by a 110-strong group of shareholders that comprises the founding family and former executives of Takeda Pharmaceutical Co. Ltd., Japan's largest drug manufacturer, Christophe Weber has been approved as the company's first foreign president and chief executive officer. Read More
HONG KONG – China has indicted two investigators linked to the bribery scandal that has rocked Glaxosmithkline plc. The couple – 58-year-old British man Peter William Humphrey and his 61-year-old American Chinese wife Yu Yingzeng – was arrested in Shanghai last August. Prosecutors at the No.1 branch of Shanghai Municipal Procuratorate announced the indictments on Sunday. The couple was charged with illegally obtaining private information of Chinese citizens. They may face up to three years imprisonment. Read More
Suzhou Alphamab Co. Ltd. is among the new generation of Chinese biopharmas moving rapidly along the evolutionary curve from contract research activities such as high-throughput screening, analytical biology and process development to the construction of a pipeline of biosimilars and, most recently, the development of novel compounds directed at cancer, autoimmune and infectious diseases. Read More
Beike Biotechnology Co. Ltd., of Shenzhen, China, said following the recent Chinese Food and Drug Administration acceptance of its investigational new drug application seeking use of human umbilical cord-derived mesenchymal stem cells to treat lupus, the company anticipates approval to move ahead with the treatment by the end of this year. Read More
Strand Life Sciences, of Bangalore, India, appointed Scott Storrer president of North America. He will oversee strategy, expansion and operation of Strand Genomics Inc.. Read More
